Driven by investments in genetic research and the increasing prevalence of genetic disorders, the antisense and RNAi therapeutics market was valued at USD 5.10 Billion in 2024. Forecasted to grow at a CAGR of 18.70% during 2025-2034, the market is projected to reach USD 28.32 Billion, highlighting rapid expansion in RNA-based therapies. https://www.expertmarketresearch.com/reports/antisense-and-rnai-therapeutics-market